Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pembrolizumab/Lenvatinib +/- hdFMT in R/R Melanoma
NCT06030037Phase 2Withdrawn
- Start
- Mar 2025
- Primary completion
- Dec 2029
- Modality
- Live Biotherapeutic Products
01
Overview
A Phase 2 trial of Fecal Microbiota Transplantation Capsule in melanoma. Planned start Mar 2025; status: withdrawn.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT06030037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06030037.